Safe Pro Group Inc Receivables Turnover Ratio (SPAI), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Safe Pro Group Inc   (NASDAQ: SPAI)
 

Safe Pro Group Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Safe Pro Group Inc 's ability to collect accounts receivable sequentially worsen to 7.23, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Safe Pro Group Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 50 days, from 13 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 204 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 459 to 465.

What is Receivable Turnover Ratio?
What is Safe Pro Group Inc Selling?


What is Receivable Turnover Ratio?





SPAI Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 3512.17 % 291.02 % -19.13 % -81.76 % -6.81 %
Y / Y Revenue Change 1336.15 % 560.24 % -74.35 % -69.34 % -85.57 %
Receivable Turnover Ratio (TTM) 7.23 27.29 12.46 23.2 14.98
SPAI's Total Ranking # 465 # 459 # 829 # 417 # 608
Accounts Receivable average collection period days 51 13 29 16 24
Seq. Receivable Change 2156.56 % -38.29 % 147.63 % 4.76 % 144.28 %
Seq. Revenue Change 9.17 % 435.84 % 124.51 % 9.35 % -49.81 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 72
Healthcare Sector # 205
Overall Market # 465

Receivable Turnover Ratio Statistics
High Average Low
62.16 25.63 7.23
(Jun 30 2024)   (Jun 30 2026)






Financial Statements
Safe Pro Group Inc 's Accounts Receivable $ 1 Millions Visit SPAI's Balance sheet
Safe Pro Group Inc 's Sales TTM $ 3 Millions Visit SPAI's Income Statement
Sources of SPAI's Revenues Visit SPAI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SPAI's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SPAI's Growth Rates SPAI's Roa SPAI's Inventory Turnover Ratio SPAI's Dividend Comparisons
SPAI's Profitability Ratios SPAI's Roi SPAI's Asset Turnover Ratio SPAI's Dividend Growth
SPAI's Valuation Ratios SPAI's Roe SPAI's Financial Strength Ratios SPAI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Community Health Systems Inc   5.63 $ 11,983.000  Millions$ 2,129.500  Millions
Surgery Partners Inc   5.61 $ 3,366.300  Millions$ 600.375  Millions
Intelligent Bio Solutions Inc   5.51 $ 4.215  Millions$ 0.765  Millions
Johnson and Johnson  5.47 $ 97,929.000  Millions$ 17,889.000  Millions
Merck and Co Inc   5.47 $ 66,569.000  Millions$ 12,167.250  Millions
Quanterix Corporation  5.45 $ 152.716  Millions$ 28.030  Millions
Brightspring Health Services Inc   5.45 $ 5,877.918  Millions$ 1,079.324  Millions
Rigel Pharmaceuticals Inc  5.43 $ 276.785  Millions$ 50.994  Millions
Igc Pharma Inc   5.36 $ 1.101  Millions$ 0.206  Millions
Strata Critical Medical Inc   5.27 $ 211.642  Millions$ 40.126  Millions
Elutia Inc   5.16 $ 11.353  Millions$ 2.198  Millions
West Pharmaceutical Services Inc   5.12 $ 3,326.900  Millions$ 649.250  Millions
Repligen Corp  5.09 $ 785.101  Millions$ 154.205  Millions
Progyny Inc   5.09 $ 1,311.298  Millions$ 257.570  Millions
Pfizer Inc  4.98 $ 63,696.000  Millions$ 12,802.250  Millions
Plus Therapeutics Inc   4.90 $ 4.203  Millions$ 0.858  Millions
Ligand Pharmaceuticals Incorporated  4.77 $ 290.542  Millions$ 60.966  Millions
Bausch and Lomb Corp  4.65 $ 5,324.000  Millions$ 1,144.000  Millions
Davita Inc   4.64 $ 14,009.646  Millions$ 3,018.719  Millions
Orasure Technologies Inc  4.62 $ 111.978  Millions$ 24.227  Millions
Yunhong Green Cti Ltd   4.58 $ 20.662  Millions$ 4.513  Millions
Bionexus Gene Lab Corp   4.48 $ 3.127  Millions$ 0.697  Millions
Bellevue Life Sciences Acquisition Corp  4.47 $ 1.809  Millions$ 0.404  Millions
Vaso Corporation  4.44 $ 80.220  Millions$ 18.048  Millions
Neurocrine Biosciences Inc   4.40 $ 3,373.900  Millions$ 767.475  Millions
Organon and Co   4.31 $ 6,139.000  Millions$ 1,422.750  Millions
Alkermes Plc   4.30 $ 1,667.652  Millions$ 388.132  Millions
Glaukos Corp  4.29 $ 500.031  Millions$ 116.471  Millions
Inspiremd Inc   4.12 $ 10.502  Millions$ 2.550  Millions
Medinotec Inc   4.07 $ 10.247  Millions$ 2.519  Millions

Date modified: 2026-08-17T17:25:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.